Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Karyopharm Therapeutics (KPTI) Receivables - Other (2016)

Karyopharm Therapeutics (KPTI) has disclosed Receivables - Other for 1 consecutive years, with $154000.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Receivables - Other changed N/A year-over-year to $154000.0, compared with a TTM value of $154000.0 through Dec 2016, changed N/A, and an annual FY2016 reading of $154000.0, changed N/A over the prior year.
  • Receivables - Other was $154000.0 for Q4 2016 at Karyopharm Therapeutics.
  • Across five years, Receivables - Other topped out at $154000.0 in Q4 2016 and bottomed at $154000.0 in Q4 2016.